Pfizer (PFE) Market Capitalization, Earnings, Price, Holders
Symbol: PFE Rank: #41 Price: $38.125(-0.84526%)

Market Cap: $218.6B($-1.8B) Industry: Drug Manufacturers General Sector: Healthcare Country: United States Insiders: 0.049% Institutions: 71.093%
Pfizer Inc. Technicals

52 Week High: $54.46

52 Week Low: $38.13

50 Day MA: $45.89

200 Day MA: $48.01

52 Week Trading Range


Low: $38.13

High: $54.46

Daily Trading Range


Low: $38.02

High: $38.43

Market capitalization history for Pfizer (PFE) in USD

As of November 2023, Pfizer (PFE) has a market cap of $218.6 billion. Our data points out that PFE is ranked #41 in the world. A company's market capitalization is the present value of all of its outstanding shares, and it is commonly used to give a sense of how much the stock of a company would be worth at today's exchange rates. PFE's market cap is -0.845256% down from the last trading day.

PFE Statistics

Market Cap
Revenue TTM
Gross Profit TTM
Operating Margin TTM
Shares Outstanding
Shares Float
Trading Volume
P/E Ratio
PEG Ratio
Revenue Per Share
Dividend Per Share
Dividend Yield
Quote Type
Leaf logo
CDP Climate Change Score (PFE)

Latest News

Pfizer (PFE) Shares Stats
Pfizer (PFE) Valuation
Trailing P/E $7.4159
Forward P/E $10.9649
Price Sales TTM $3.013
Price Book MRQ $3.3014
Enterprise Value $305,367,375,975
Enterprise Value Revenue $3.0574
Enterprise Value Ebitda $7.7414
Pfizer Inc. Details

Address: 235 East 42nd Street

City: New York

Zip: 10017

Phone: 212 733 2323


IPO Date: 2012-08-13

CEO: Dr. Albert Bourla D.V.M., DVM, Ph.D.

Employees: 79,000

What is PFE about?

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.